Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 554
A002 Cell Blood Count 27 2 042
A005 Sedimentation rate 16 1 210
A008 Reticulocytes 13 983
A009 Matching of blood and compatibility test 265 20 039
A010 Time of coagulation 13 983
A015 Time of bleeding 13 983
M125 Malaria test 67 5 067
URINE ANALYSIS
B500 Standard urine test 13 983
B502 Standard urine test with microscopy 24 1 815
B510 Urine pregnancy test (screening) 13 983
B511 Nechiporenko urine test 20 1 512
B512 Zimnitsky urine test 53 4 008
B513 3-portions urine test examination 40 3 025
B514 2-portions urine test examination 27 2 042
B515 Urine precipitate - Microscopy 13 983
B517 Creatinine Clearance 53 4 008
STOOL ANALYSIS
B306 Elastase Pancreatic 33 2 495
M105 Coprology total 27 2 042
M110 Coprology (occult blood) 13 983
M111 Carbohydrates in faeces 40 3 025
M115 Enterobiasis 20 1 512
M120 Eggs of helminths (+protozoa) 27 2 042
M122 Protozoa in faeces 20 1 512
M390 Adenovirus and rotavirus (in stool) 28 2 117
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 3 100
M391 Helicobacter pylori(in stool) 27 2 042
M393 Verotoxin in stool 50 3 781
M394 Norovirus in stool 25 1 890
M395 Calprotectin in stool (quantitative) 50 3 781
M396 Clostridium Difficile Toxin A & B 65 4 915
SPUTUM ANALYSIS
M150 Standard sputum test 27 2 042
M002 Nasal slime general clinical research 27 2 042
M355 M. Tuberculosis in sputum 33 2 495
SKIN& NAIL PLATES
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 554
M210 Demodex folliculorum 20 1 512
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 343
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 512
M221 Standard Cervical Smear Test 20 1 512
M222 Standard Urethral Smear Test 20 1 512
M223 Standard prostatic fluid test 27 2 042
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 2 042
B621 Standard Serous Fluid test 27 2 042
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 495
B623 Glucose in cerebrospinal fluid 17 1 286
B624 Protein in cerebrospinal fluid 17 1 286
HEMOSTASIS SYSTEM
A020 APTT 16 1 210
A025 Prothrombin+INR 27 2 042
A027 Thrombin time 22 1 664
A030 Fibrinogen 16 1 210
A035 Antithrombin III 27 2 042
C139 Protein-C 47 3 554
C142 Protein-S 47 3 554
C515 D-DIMER 60 4 537
C305 Lupus anticoagulant (panel) 53 4 008
A033 Platelet Aggregation 83 6 276
A031 FACTOR VON 170 12 855
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 269
BLOOD DRUG RATES
B142 Folic acid 27 2 042
C710 Determination of ethanol in the blood 60 4 537
T010 Digoxin 78 5 898
T015 Phenobarbital 53 4 008
T020 Phenytoin 53 4 008
T025 Valproic Acid 53 4 008
T030 Carbamazepine 53 4 008
T080 Tacrolimus 35 2 647
T085 Levetiracetam (Keppra) 100 7 562
T097 Therapeutic drug monitoring of Topiramate 22 1 664
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 22 1 664
T100 Determination of the concentration of Amikacin in the blood 40 3 025
T101 The determination of the concentration of Gentamicin in the blood 40 3 025
T102 Determine the concentration of Vancomycin in the blood 40 3 025
NARCOTIC SCREENING
T035 Methamphetamine 33 2 495
T040 Cannabis 33 2 495
T045 Cocaine 33 2 495
T050 Opiates / QUICK TEST 33 2 495
T060 Сotinine 33 2 495
T070 Benzodiazepines 53 4 008
T075 Drug screening in urine 53 4 008
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 2 949
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 14 141
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 4 008
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 2 042
B002 Iron saturation of transferrin + Transferrin + Iron 39 2 949
B003 Ceruloplasmin 50 3 781
B004 Eosinophil Cationic Protein (ECP) 50 3 781
B007 Cuprum 22 1 664
B100 Glucose 13 983
B101 Standard glucose tolerance test 33 2 495
B102 Vitamin D 107 8 091
B103 Vitamin A 83 6 276
B104 Vitamin B1 83 6 276
B105 Cholesterol 13 983
B107 Pregnancy glucose tolerance test 33 2 495
B108 Vitamin B5 83 6 276
B109 Vitamin B6 83 6 276
B110 Cholesterol-HDL 20 1 512
B112 Vitamin C 83 6 276
B113 Vitamin E 83 6 276
B114 Vitamin K 83 6 276
B115 Cholesterol-LDL 20 1 512
B118 Lactate 25 1 890
B120 Triglycerides 13 983
B122 Angiotensin converting enzyme (ACE) 45 3 403
B125 Bilirubin total 13 983
B130 Bilirubin direct 13 983
B135 Albumin 13 983
B137 Homocysteine 67 5 067
B140 Creatinine 13 983
B144 Zink 38 2 874
B145 Iron 16 1 210
B148 Litium 74 5 596
B150 Iron binding capacity 20 1 512
B155 Total protein 13 983
B160 Protein fractionation (Electrophoresis) 27 2 042
B165 Lipoprotein A 27 2 042
B166 APO-A-1 protein 27 2 042
B167 APO-B protein 27 2 042
B170 Urea 13 983
B175 Uric acid 13 983
B180 Fructosamine 20 1 512
B187 Determination of prealbumin in blood serum 89 6 730
B200 Calcium (total) 16 1 210
B202 Calcium (ionised) 20 1 512
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 11 343
B205 Sodium/Potassium/Chloride 16 1 210
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 2 042
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 2 042
B210 Magnesium 13 983
B215 Phosphate inorganic 13 983
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 10 284
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 554
B219 Study of dialysate for electrolyte composition, pH, glucose 131 9 906
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 554
B300 Amylase 16 1 210
B305 Amylase pancreatic 16 1 210
B310 Lipase 16 1 210
B315 Lactatedehydrogenase (LDH) 13 983
B317 Erythropoietin 47 3 554
B320 Creatine Kinase 13 983
B325 Creatine Kinase MB 16 1 210
B330 Gamma Glutamyle Transferase (GGT) 13 983
B335 Acid phosphatase 16 1 210
B340 Alk. Phosphatase 13 983
B345 Alanine Amino Transferase (ALT) 13 983
B350 Aspartate Amino Transferase (AST) 13 983
B360 Cholinesterase 18 1 361
B400 C-Reactive Protein 20 1 512
B401 C-reactive protein high sensitivity 30 2 269
B405 Rheumatoid Factor 20 1 512
B410 Anti-streptolysin O titre 20 1 512
B411 Alfa-1-antitrypsin 27 2 042
C415 Ferritin 27 2 042
B430 Haemoglobin A1C 22 1 664
B435 Myoglobin 47 3 554
B440 Transferrin 27 2 042
B445 Troponin I 47 3 554
B450 Troponin T 47 3 554
B451 BNP (brain natriuretic peptide) 87 6 579
B556 The N-terminal peptide NT-proBNP 88 6 655
B604 Alpha-2-Macroglobuline 47 3 554
B610 Haptoglobin 47 3 554
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 9 831
B702 Procalcitonin (quant) 60 4 537
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 554
B025 Microproteinuria 13 983
B132 Urea (random portion) 12 907
B133 Uric acid (random portion) 12 907
B139 The content of Cu (copper) in the urine (a single portion of urine) 12 907
B173 Glucose (random portion) 13 983
B182 Alpha Amylase (random portion) 18 1 361
B505 NA+/K+/Cl (random portion) 20 1 512
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 343
B134 Calcium (random portion) 18 1 361
B008 The content of Cu (copper) in the urine (daily) 13 983
B703 Gas chromatography of urine (organic aciduria) 250 18 905
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 361
B141 Creatinine (24h) 18 1 361
B171 Urea (24h) 18 1 361
B176 Uric acid (24h) 18 1 361
B177 Phosphate inorganic (24h) 18 1 361
B178 Magnesium (24) 18 1 361
B179 Glucose (24h) 18 1 361
B183 Total Protein (24h) 18 1 361
B506 Na (24h) 20 1 512
B507 K (24h) 20 1 512
B508 Cl (24h) 20 1 512
B516 Calcium urine test (24h) 22 1 664
B550 Oxalate in urine 40 3 025
B555 5-hydroxyindoleacetic acid in urine 53 4 008
B558 Determination of Beta-2-microglobulin (single dose of urine) 24 1 815
B562 Urine protein electrophoresis 40 3 025
B520 Stone chemistry - Profile 67 5 067
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 437
B420 Immunoglobulin M (IgM) 19 1 437
B425 Immunoglobulin G (IgG) 19 1 437
C299 Circulating Immune Complex 22 1 664
C300 IgE total 27 2 042
C285 Interferon sensibility state 293 22 157
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 15 124
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 15 124
C293 Compliment Componenta C3 33 2 495
C294 Compliment Componenta C4 33 2 495
C295 Neutrophilic Bactericidal Activity (HCT test) 27 2 042
C290 Interleukin 6 34 2 571
C291 Interleukin 8 34 2 571
C296 Interleukin 10 34 2 571
C298 Tumor Necrosis Factor 34 2 571
C281 Interleukin 1 Beta 50 3 781
B704 Oligoclonal IgG in liquorrhea & serum 120 9 074
Diagnosis Of Auto-Immune Diseases
C225 Thyroglobulin antibody 33 2 495
C230 Thyroperoxidase antibody 33 2 495
C231 Auto AB TSH-receptor 53 4 008
C233 Antispermatic Antibodies 67 5 067
C235 AB Insulin IgG 40 3 025
C236 AB insular beta-cells 67 5 067
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 647
C500 Nuclear antibody (IF) 47 3 554
C505 Cardiolipin antibody IgG 47 3 554
C506 Cardiolipin antibody IgA 25 1 890
C533 Anti-dsDNA 53 4 008
C534 Anti-ssDNA 53 4 008
C535 Phospholipid Antibody IgG 53 4 008
C536 Phospholipid Antibody IgM 53 4 008
C830 Antibodies Prothrombin 40 3 025
C845 Antibodies Reticulin 47 3 554
C846 Antibodies Endomysium 47 3 554
C847 Antibodies Platelet 53 4 008
C848 Antibodies Basic Skin Membrane 73 5 520
C840 Antibodies Gliadin IgA 40 3 025
C850 Antibodies Gliadin IgG 40 3 025
C841 Anti-Transglutaminase IgG 47 3 554
C842 Anti-Transglutaminase IgA 47 3 554
C023 Cardiolipin antibodies, IgM 50 3 781
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 6 276
C035 Cytoplasmic antigen antibodies Jo-1 (anti-Jo-1) 83 6 276
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 781
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 781
C851 Beta2 – glycoprotein antibodies 50 3 781
C852 Annexin V antibodies 50 3 781
C853 ENA – extractive nuclear antibodies screen 61 4 613
C101 Anti-smooth muscle antibodies (ASMA) 50 3 781
C102 Anti-mitochondrial antibodies (AMA) 50 3 781
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 403
C203 Scl-70 antibodies 50 3 781
C240 Antibodies acetylcholine receptor 160 12 099
C241 Antibodies aquaporin 4( NMO) 80 6 050
C242 Antibodies skeletal muscles 70 5 293
C243 Antibodies gangliosides, blot 90 6 806
C244 Myositis antibodies, blot 90 6 806
C245 Anti-neuronal antibodies, blot 110 8 318
C246 Antibodies NMDA receptor 150 11 343
C247 Antibodies Sm 50 3 781
C248 Antibodies gliadine deamidated peptides IgG 45 3 403
C249 Antibodies gliadine deamidated peptides IgA 45 3 403
C250 Antibodies RNP-70 45 3 403
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 21 778
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 22 081
C253 Blood test on APG 100 7 562
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 50 3 781
C256 Definition of CD20 in peripheral blood 54 4 083
C257 Typing of CD-34 + cells 54 4 083
C258 Myelogram 122 9 226
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 75 5 671
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 75 5 671
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 16 636
A069 Determination of free light chains FLC in blood 55 4 159
ONCOLOGICAL TESTS
C405 PSA total 29 2 193
C410 PSA free 29 2 193
C420 AFP 29 2 193
C425 CEA 29 2 193
C430 CA 125 38 2 874
C435 CA 19-9 29 2 193
C440 CA 15-3 29 2 193
C442 CA 72 - 4 40 3 025
C443 Neuron-Specific Enolase (NSE) 60 4 537
C445 B2 microglobulin 33 2 495
C820 Cyfra-21-1 40 3 025
C822 Squamous Cell Carcinoma (SCC) 39 2 949
C821 UBC (Bladder Cancer Antigen) in urine 39 2 949
C823 HE4 40 3 025
C824 Chromogranin A 55 4 159
SEROLOGY
Syphilis Diagnosis
S000 Syphilis RPR 27 2 042
S001 Antibodies Treponema Pallidum IgG+IgM 27 2 042
S002 Total antibodies Treponema pallidum (quant) 30 2 269
S010 Syphilis TPHA 33 2 495
S091 Immunoblot Treponema pallidum IgG 103 7 789
S092 Immunoblot Treponema pallidum IgM 103 7 789
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 495
A055 Antierythrocytic antibodies (screening) 40 3 025
A056 Direct Cumbs test 33 2 495
A061 Detecting Kell antigen sistem 33 2 495
A064 Phenotyping Rh and Kell 35 2 647
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 554
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 5 974
C004 Anti-HAV total 40 3 025
C006 Anti-HAV IgM 47 3 554
C008 HBsAg 27 2 042
C009 HBsAg (conf.test) 47 3 554
C010 HBeAg 47 3 554
C012 Anti-HBc total 40 3 025
C014 Anti-HBc IgM 47 3 554
C016 Anti-Hbe 47 3 554
C018 Anti-HBs quant. 47 3 554
C020 Anti-HCV total/ Anti-HCV IgG 40 3 025
C021 Anti-HCV IgM 44 3 327
C025 Anti-HCV (conf.test) 53 4 008
C007 Hepatitis D Virus HDV antibodies, total 28 2 117
C011 HDV antibodies, IgM 28 2 117
C013 HEV antibodies, IgG 28 2 117
C015 HEV antibodies, IgM 28 2 117
C026 Anti-CMV IgG 29 2 193
C028 Anti-CMV IgM 33 2 495
S200 Cytomegalovirus (CMV) IgG Avidity 53 4 008
C030 Anti-Rubella IgG 29 2 193
C032 Anti Rubella IgM 33 2 495
S210 Rubella IgG Avidity 38 2 874
C031 Anti-Parvovirus B19 IgG 40 3 025
C033 Anti-Parvovirus B19 IgM 40 3 025
C034 Anti Mumps IgG 53 4 008
C036 Anti Mumps IgM 53 4 008
C038 Anti Measles IgG 53 4 008
C040 Anti Measles IgM 53 4 008
C044 Anti-HSV 1 IgG 47 3 554
C046 Anti-HSV 1 IgM 53 4 008
C048 Anti-HSV 2 IgG 47 3 554
C050 Anti-HSV 2 IgM 53 4 008
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 554
C052 Anti-Varicella Zoster IgG 53 4 008
C054 Anti Varicella Zoster IgM 53 4 008
C058 Anti-EBV-VCA IgG 53 4 008
C060 Anti-EBV-VCA IgM 53 4 008
C450 Adenovirus infection 67 5 067
C856 Anti- encephalitis IgG 55 4 159
C857 Anti- encephalitis IgM 55 4 159
C094 IgG Respiratory syncytial virus 35 2 647
C096 IgM Respiratory syncytial virus 35 2 647
C152 IgG Dengue virus 25 1 890
C153 IgM Dengue virus 25 1 890
C154 Antibodies to Clostridium tetani (quantitative) 35 2 647
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 4 159
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 4 159
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 554
C064 Helicobacter pylori antibody blot 80 6 050
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 554
C080 Mycobacterium tuberculosis antibodies total 53 4 008
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 5 067
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 5 067
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 5 067
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 9 831
C090 Borrelia burgdorf. IgG (qual) 67 5 067
C091 Borrelia burgdorf. IgM (qual) 67 5 067
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 890
C165 Serological diagnosis of borreliosis (immunochip) in blood 13 983
C519 Anti IgG Legionella pneumophila (qual.) 89 6 730
C522 Anti IgM Legionella pneumophila (qual.) 89 6 730
C645 Brucella IgG 67 5 067
C647 Brucella IgM 67 5 067
D070 Chlamydia pneumoniae IgA 53 4 008
D071 Chlamydia pneumoniae IgG 53 4 008
D072 Anti IgM Chlamydia pneumoniae 53 4 008
D073 Chlamydia psittaci IgG (qual) 67 5 067
D074 Chlamydia psittaci IgM (qual) 67 5 067
D077 Chlamydia psittaci IgA (qual) 67 5 067
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 134
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 756
D110 Mycoplasma pneumoniae IgA (quant) 40 3 025
D115 Mycoplasma pneumoniae IgG (qual) 40 3 025
D120 Mycoplasma pneumoniae IgM (qual) 40 3 025
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 269
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 269
D322 AB Shigella flexneri (total) 60 4 537
D323 AB Shigella sonnei (total) 60 4 537
S070 Ureaplasma urealiticum IgA 67 5 067
S075 Ureaplasma urealiticum IgG 67 5 067
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 664
S232 Anti-Salmonella Typhi Vi-antigen 22 1 664
S233 Anti-Corinebacterium Diphtheriae 22 1 664
C053 Helicobacter pylori IgM 44 3 327
C063 Helicobacter pylori IgA 44 3 327
C103 Immunoblot Borrelia burgdorferi IgG 60 4 537
C104 Immunoblot Borrelia burgdorferi IgM 60 4 537
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 756
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 756
S006 Antigen Legionella pneumophilla in urine 30 2 269
S007 Determination of antigen Legionella pneumophilla in urine (express test) 25 1 890
S008 Determination of streptococcus pneumoniae antigen 25 1 890
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 5 067
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 5 067
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 5 067
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 5 067
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 554
D312 Lamblia intestinalis IgM 47 3 554
D315 Antibody to ascaris antigen IgG (qual.) 40 3 025
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 5 067
D325 Antibodies to Opistorchis IgG (quantitatives) 67 5 067
D326 Antibodies to Toxocara IgG (quantitative) 67 5 067
D327 Antibodies to Trichinella lgG (quantitative) 67 5 067
D328 Antibodies Ascaris IgG (quantitative) 67 5 067
D329 The blood test for trichinosis (rostirolla) 17 1 286
D330 The blood test for toxocariasis (rostirolla) 17 1 286
C049 Strongyloides stercoralis antibodies 44 3 327
C051 Taenia solium antibodies, IgG 44 3 327
C055 Fasciola hepatica antibodies, IgG 44 3 327
C057 Schistosoma mansoni antibodies, IgG 44 3 327
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 193
C024 Toxoplasma gondii IgM (qual) 38 2 874
C037 Leishmania infantum antibodies 60 4 537
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 327
S230 Trichomonas antibodies 30 2 269
S220 Toxoplasma IgG Avidity 46 3 479
C625 Entamoeba sp AB (total) 80 6 050
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 2 042
C205 Total T3 27 2 042
C210 Free T3 27 2 042
C215 Total T4 27 2 042
C220 Free T4 27 2 042
C222 Calcitonin 40 3 025
C223 Thyroglobulin 40 3 025
C224 Thyroid Binding Globulin (TBG) 40 3 025
Reproduction
B151 Dihydrotestosterone 53 4 008
C100 Follicle stimulating hormone 29 2 193
C105 Luteinising hormone 29 2 193
C106 Globulin, linking sex hormones (SHBG) 47 3 554
C110 Testosterone 29 2 193
C115 Prolactin 29 2 193
C117 Testosterone Free 47 3 554
C122 Prostate Health Index (PHI) 180 13 612
C125 Estradiol 29 2 193
C126 Estriol Free 38 2 874
C130 Progesterone 29 2 193
C141 Inhibin В 93 7 033
C143 AMH (Anti-Mullerian Hormone) 93 7 033
C159 Definition of Macroprolactin (includes the definition of prolactin) 10 756
C227 Androstenedione 60 4 537
C400 Beta HCG 33 2 495
C402 PAPP-A 44 3 327
C404 Androstanediol glucuronide 50 3 781
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 70 5 293
IVF83 Evaluation of ovarian reserve 197.6 14 942
AMH (Anti-Mullerian Hormone)
Follicle stimulating hormone
Fertility specialist consultation
C460 Determination of chorionic gonadotropin, (free Beta-subunit), ASTRAIA program 64 4 840
C461 Determination of plasma protein A (PAPP-A), ASTRAIA program 64 4 840
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 2 874
B536 Free cortisol (urine, 24h) 40 3 025
B531 17-alpha-Hydroxy-Progesteron 29 2 193
C120 Cortisol 29 2 193
C135 Dehydroepiandrosterone 33 2 495
C140 Adrenocorticotrophin 53 4 008
C160 Determination of unsaturated fatty acids of the omega-3 family: docosahexaenoic (DHA),eicosapentaenoic (EPA) - in blood 65 4 915
C161 Calculation of the Omega-3 index - the ratio of docosahexaenoic (DHA) and eicosapentaenoic (EPA) fatty acids in blood: an assessment of the risk of cardiovascular disease and myocardial infarction 70 5 293
C162 Determination of unsaturated fatty acids of the family Omega-6: linoleic, linolenic, arachidonic acid - in blood 65 4 915
C163 The definition of unsaturated fatty acids of the family Omega-3 and Omega-6: docosahexaen (DHA), eicosapentaenoic (EPA), linoleic, linolenic, arachidonic acid - in blood 125 9 452
C452 Determination of cortisol in saliva 25 1 890
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 537
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 104 7 864
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 9 604
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 9 604
G123 Mucoviscidosis CFTR 300 22 686
G423 A study of the fragmentation of sperm DNA by the method of SCD 170 12 855
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 170 12 855
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 479
C132 Parathormone 47 3 554
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 327
C147 Bone resorption - deoxypiridinolin 67 5 067
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 6 050
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 479
B527 Somatomedin-C 46 3 479
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 3 025
B533 Proinsulin 60 4 537
B534 С-peptide 47 3 554
B539 Antibody-GAD 53 4 008
C108 Leptin 53 4 008
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 671
C158 Melatonin 48 3 630
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 4 008
BIOGENIC AMINES
C700 Serotonin 60 4 537
C800 Histamine 60 4 537
C900 Tryptase 75 5 671
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 537
C157 Catecholamines and serotonin 36 2 722
S100 Determination of Metanefrine (total) in daily urine 93 7 033
S101 Determination of Metanefrine (free) in daily urine 93 7 033
S102 Determination of Normetanefrine (total) in daily urine 93 7 033
S103 Determination of Normetanefrine (free) in daily urine 93 7 033
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 512
C311 Specific IgE for Allergen Mix / qual 33 2 495
C312 Single recombinant allergic components, inhalation (One name) 20 1 512
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 832
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 512
C315 General Inhalation Allergy Panel 160 12 099
C340 General Food Panel 160 12 099
C350 Allergy Panel/ primary screening 120 9 074
C351 Allergy pediatric panel, IgE (20 allergens) 156 11 797
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 2 117
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 664
С362 Antibacterial drugs (antibiotics) (specific IgE), one name. 9 681
С363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 9 681
С364 Local anesthetics (specific IgE). One name. 9 681
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 17 1 286
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 17 1 286
C367 Local anesthetics (specific IgG). One name. 17 1 286
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 2 042
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 664
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 32 138
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 907
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 24 198
С360 Complex diagnostics of food intolerance (panel of 96 tests): specific IgG4 to 115 products (85 individual and 30 mixed doubles), Ascaris, Candida), Dr.Fooke 216 16 334
С361 Complex diagnostics of food intolerance (panel of 192 tests): specific IgG4 to 203 products (181 individual and 22 mixed doubles), Ascaris, Candida), Dr.Fooke 347 26 240
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 647
P019 DNA Salmonella species in stool 25 1 890
P021 Colibacillosis 40 3 025
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 2 949
P009 Mycoplasma pneumoniae DNA 22 1 664
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 5 067
P030 HSV I & II 20 1 512
P031 Human Papilloma virus 31, 33 20 1 512
P032 Human Papilloma virus 6,11 20 1 512
P033 Herpes Simplex virus II 20 1 512
P035 H. Papilloma virus 16, 18 20 1 512
P042 Varicella-Zoster virus 20 1 512
P070 Cytomegalovirus 20 1 512
P080 Epstein-Barr virus 20 1 512
P105 Human Papilloma virus sp. 20 1 512
P004 Rubella Virus in blood (qual) 40 3 025
P120 Herpes Simplex virus VI (qual) 18 1 361
P125 Enterovirus (RNA) 33 2 495
P126 DNA Pneumocystis carinni 17 1 286
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 781
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 5 293
P129 RNA Zika virus (blood) 80 6 050
P130 RNA Zika virus (ejaculate) 33 2 495
P131 RNA Zika virus (Amniotic fluid) 33 2 495
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 5 293
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 269
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 134
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 52 3 932
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 512
P036 M.Tuberculosis-M.bovis 22 1 664
P038 Streptococcus group A (pyogenes) 22 1 664
P065 Listeria monocytogenes 22 1 664
P075 Pseudomonas aeruginosa 22 1 664
P085 Bordetella pertussis (PCR) 22 1 664
P095 Helicobacter pylori 38 2 874
P097 Haemophilus influenzae 20 1 512
P098 Streptococcus pneumoniae 20 1 512
P099 DNA Treponema pallidum 20 1 512
P103 Legionella pneumophila 10 756
P138 Study of feces on Yersinia pseudotuberculosis by PCR 10 756
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 512
P005 Mycoplasma hominis 20 1 512
P006 Mycoplasma genitalium 20 1 512
P015 Ureaplasma species 20 1 512
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 512
P020 Neisseria gonorrhoeae 20 1 512
P025 Gardnerella vaginalis 20 1 512
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 512
P012 Toxoplasma gondii 22 1 664
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 664
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 4 008
P045 Hepatitis B qualitive (HBV-DNA) 33 2 495
P050 Hepatitis C quant. (HCV-RNA) 253 19 132
P055 Hepatitis C qualitive (HCV-RNA) 38 2 874
P060 HCV-RNA (genotype determination) 40 3 025
P061 Hepatite G qual. (HGV-RNA) 40 3 025
P062 Hepatite D qual. (HDV-RNA) 40 3 025
P008 Hepatitis A Virus RNA (HAV-RNA) 40 3 025
P007 Determination of DNA of hepatitis TT virus (qual.) (TTV-DNA) 33 2 495
P063 Genotype of hepatitis B 35 2 647
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 671
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 14 065
P132 Definition of HIV RNA (type 1) (quantitative) 76 5 747
P137 Blood test for Dirofilariasis by PCR 25 1 890
GENETIC ANALYSIS
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 11 343
G122 SNP identification in human IL28B gene 60 4 537
G124 Genetic panel "Hypertension" 220 16 636
G125 Genetic panel "Ischemic heart disease" 230 17 393
G126 Genetic panel "Lipid metabolism, base panel" 220 16 636
G127 Genetic panel "Plasma factors of coagulation system" 220 16 636
G128 Genetic panel "Aggregation factors of coagulation system" 220 16 636
G129 Genetic panel "Folate cycle" 220 16 636
G130 Genetic panel "Osteoporosis" 250 18 905
G131 Genetic panel "Obesity" 220 16 636
G132 Genetic panel "Crohn's disease" 230 17 393
G133 Genetic panel "Warfarin" 250 18 905
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 17 393
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 15 880
G136 FISH panel Myelodysplastic syndrome (6 probes) 220 16 636
G137 CYP2D6 analysis polymorphisms 140 10 587
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 32 516
G139 Familial adenomatous polyposis , polypoid colon cancer 430 32 516
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 43 406
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 62 008
G156 BRCA1 и BRCA2 polymorphism 225 17 014
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 75 620
G159 Sequence SCN1 A (Dravet syndrome) 825 62 386
G160 Fragile X mental retardation syndrome (methylation) 188 14 217
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 19 888
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 128 553
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 10 209
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 3 025
G165 Paternity test 480 36 297
G167 Non Invasive Fetal Rhesus factor Determination 188 14 217
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 11 343
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 760 57 471
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 760 57 471
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 78 644
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 52 934
G197 Calreticulin (CALR) 77 5 823
G198 Ehlers-Danlo syndrome type IV. Search for frequent mutations in the PLOD1 gene 130 9 831
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 538 40 683
G208 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (optimal) 132 9 982
G209 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (expanded) 732 55 354
G210 Predisposition to osteoporosis 95 7 184
G211 Sports injury (professional sports) 156 11 797
G212 Choosing sport - strength or speed 120 9 074
G213 Stamina (career guidance) 84 6 352
G214 Stress resistance (career guidance) 108 8 167
G215 Acne 348 26 316
G216 Genetic predisposition to breast cancer and ovarian cancer 120 9 074
G217 Genetic predisposition to cervical cancer (economy) 156 11 797
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 17 393
G222 Genetic predisposition to thrombophilia (early gestation, preparing for pregnancy and childbirth) 230 17 393
G224 Genetic predisposition to late gestosis and preeclampsia 175 13 233
G226 Genetic predisposition to hirsutism and hyperandrogenism 36 2 722
G227 Genetic predisposition to metabolic syndrome 252 19 056
G228 The sensitivity of the androgen receptor 108 8 167
G229 Skin cancer, melanoma (genetical) 228 17 241
G230 Cancer of the oral cavity and nasopharynx 60 4 537
G231 Esophageal cancer 156 11 797
G232 Stomach cancer 396 29 945
G233 Pancreas cancer 84 6 352
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 560 42 347
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 15 124
G236 Sensitivity of steroid receptors (estrogen, progesterone) 150 11 343
G237 Metabolism of steroid hormones genetic distinction 276 20 871
G238 Genetic predisposition to disruption of spermatogenesis 36 2 722
G239 Genetic predisposition to adrenal cortex function decreasing 175 13 233
G240 Genetic predisposition to a decrease in testosterone synthesis 95 7 184
G241 Genetic predisposition to hyperandrogenism 36 2 722
G242 Medullar thyroid cancer 132 9 982
G243 Follicular thyroid cancer 60 4 537
G244 Upper respiratory tract and esophagus cancer 252 19 056
G245 Allergy 84 6 352
G246 Bronchial asthma 108 8 167
G247 Bronchial asthma. Steroids resistance 60 4 537
G248 Body mass index 84 6 352
G249 Rheumatoid arthritis 45 3 403
G250 Psoriatic arthritis 60 4 537
G251 Atherosclerosis, coronary artery disease, dyslipidemia 175 13 233
G252 Hypertension 200 15 124
G253 Atherosclerotic index 150 11 343
G254 Sensorineural hearing loss 36 2 722
G255 Muscle atrophy 60 4 537
G256 Long QT syndrome 84 6 352
G257 Myopia 156 11 797
G258 Candidal vaginitis 60 4 537
G259 Bacterial vaginosis 108 8 167
G260 Hyperactivity 156 11 797
G261 Psychotrauma 204 15 426
G262 Localized scleroderma 84 6 352
G263 Utilization of xenobiotics rate 60 4 537
G264 Lactose intolerance 67 5 067
G265 Gilbert's syndrome - a confirmatory test 40 3 025
G266 Type 1 diabetes 132 9 982
G267 Type 2 diabetes 114 8 621
G268 Psoriasis 60 4 537
G269 Atopic dermatitis 132 9 982
G270 Determination of sensitivity to irinotecan (Campto) (treatment of сolorectal cancer) 36 2 722
G271 Determination of sensitivity to Erbitux and Vectibix (treatment of сolorectal cancer) 108 8 167
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 36 2 722
G273 Determination of sensitivity to Iressa, Tarceva (lung cancer treatment) 36 2 722
G274 Determination of sensitivity to Herceptin (cardiotoxicity) 36 2 722
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 12 553
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 12 553
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 191 14 443
G289 Activity GATA2 gene for prostate cancer (blood test) 166 12 553
G290 Activity IGF1 gene for prostate cancer (blood test) 166 12 553
G291 Activity IGF2 gene for prostate cancer (blood test) 166 12 553
G292 Activity IL4 gene for prostate cancer (blood test) 166 12 553
G293 Activity IL10 gene for prostate cancer (blood test) 166 12 553
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 264 19 964
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 111 8 394
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 548 41 440
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 913 69 041
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 488 36 902
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1420 107 380
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2435 184 134
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4058 306 865
G308 PGD ​​monogenic diseases 1 category of complexity 1217 92 029
G309 PGD ​​monogenic diseases 2 category of complexity 2029 153 432
G310 PGD ​​monogenic diseases 2 category of complexity 3043 230 111
G311 Genetic aptitude to myocardial infarction 175 13 233
G312 Genetic aptitude to enlargement of apoplectic attack 108 8 167
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 435 32 895
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 535 40 457
G315 Full sequencing of exome 2046 154 718
G316 Panel "Diseases of conjunctive tissue" 640 48 397
G317 Panel "Patrimony of cardiopathy" 614 46 430
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 625 47 262
G319 Search for mutations in the gene CAV 3 129 9 755
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 45 750
G321 Panel "Hypertension" 80 6 050
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 10 587
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 345 26 089
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 172 13 007
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 550 41 591
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 235 17 771
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 155 11 721
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 155 11 721
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 742 56 110
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 536 40 532
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 227 17 166
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 17 393
G333 Myriad MyRisk 3495 264 291
G334 Myriad BRCA1 Analysis 2012 152 147
G335 Myriad BRCA2 Analysis 2086 157 743
G336 Myriad COLARIS PLUS 2751 208 030
G337 Myriad MLH1 Analysis 1716 129 763
G338 Myriad MSH2 Analysis 1494 112 976
G339 Myriad MSH6 Analysis 1827 138 157
G340 Myriad PMS2 Analysis 1716 129 763
G341 Myriad MYH Sequence Analysis 1642 124 168
G342 Myriad Comprehensive MELARIS 1385 104 733
G343 Myriad Comprehensive PANEXIA 2751 208 030
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 671
G345 Molecular genetic testing for SPAST-gene mutation associated with Hereditary spastic paraplegia (HSP) 505 38 188
G346 Molecular genetic testing for ATL1-gene mutation associated with Hereditary spastic paraplegia (HSP) 464 35 088
G347 Molecular genetic testing for BSCL2-gene mutation associated with Hereditary spastic paraplegia (HSP) 217 16 409
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 11 343
G349 Molecular genetic testing for GJC2-gene mutation associated with Hereditary spastic paraplegia (HSP) 138 10 436
G350 Molecular genetic testing for CYP2U1-gene mutation associated with Hereditary spastic paraplegia (HSP) 159 12 024
G351 Molecular genetic testing for L1CAM-gene mutation associated with Hereditary spastic paraplegia (HSP) 556 42 045
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 58 4 386
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 167 12 628
G355 Myriad BRAC Analysis 2382 180 126
G356 Myriad Single-Site BRACAnalysis 954 72 141
G357 Myriad MultiSite 3 BRACAnalysis 1117 84 467
G358 Myriad Reflex BRACAnalysis 2160 163 339
G359 Myriad BRACAnalysis Rearrangement Test (BART) 1192 90 139
G360 Myriad Single-Site COLARIS 954 72 141
G361 Myriad COLARIS AP PLUS 2382 180 126
G362 Myriad Single-Site COLARIS AP 954 72 141
G363 Myriad MYH Mutation Panel 886 66 999
G364 Myriad Reflex MYH Sequence Analysis 1406 106 321
G365 Myriad Single-Site MELARIS 954 72 141
G366 Myriad Single-Site PANEXIA 954 72 141
G367 Myriad PALB2 Analysis 1761 133 166
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 78 644
G376 Molecular karyotyping abortion material OPTIMA 285 21 552
G377 Chromosomal micrometrical analysis of abortive material Standard 530 40 078
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 580 43 859
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 420 31 760
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 400 30 248
G388 The allocation and storage of DNA 20 1 512
G389 Panel "Disorders of hemostasis" 30 tokens 210 15 880
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 11 116
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 10 057
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 18 451
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 26 845
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 26 845
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 20 947
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 27 677
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 23 442
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 16 788
G425 The study of the intestinal microbiota by the method of NGS sequencing of specific 16s RNA 211 15 956
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 15 124
TISSUE TYPING
G020 HLA TYPING B27 200 15 124
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 6 050
M003 Bacterioscopic stained smear 30 2 269
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 554
M010 Mycology & Fungigram 74 5 596
M100 Disbacteriosis 107 8 091
M130 Corynebacterium diphtheriae (BL) 29 2 193
M135 Enteropathogenic bacteria (BD) 29 2 193
M170 Staphylococcus aureus 52 3 932
M350 Yersinia enterocolitica (stool culture) 52 3 932
M560 Listeria (with resistance) 38 2 874
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 15 1 134
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 512
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 134
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 134
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 52 3 932
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 52 3 932
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 11 832
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 11 343
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 562
M151 Microbiology of blood by fungi (double reseeding) 130 9 831
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 6 050
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 9 831
M156 Mycology of sputum by fungi, microscopy and culture 80 6 050
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 9 831
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 8 318
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 9 074
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 6 050
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 562
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 9 074
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 5 293
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 6 050
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 6 806
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 8 696
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 6 050
COMPLEX LABORATORY TESTS
K011 Fibro Test/ Acti Test 300 22 686
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 28 735
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 6 730
G100 TIMP-2 - study of lung cancer invasiveness 89 6 730
G008 TGF B - study of prostate cancer invasiveness 89 6 730
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 781
G010 BRCA1 4153delA 50 3 781
G011 BRCA1 185delAG 50 3 781
G012 BRCA1 C61>G 50 3 781
G014 BRCA1 2080delAA 50 3 781
G015 BRCA2 6174delT 50 3 781
G016 BRCA2 9318 delAAAA 50 3 781
G021 CHEK2 ivs2+1G>A 50 3 781
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 6 428
G053 BCR-ABL p190 t(9;22) 85 6 428
G054 BCR-ABL p230 t(9;22) 85 6 428
MUTATIONS, CHIMERISM
G097 Mutation in D816V gene c-KIT, typical of mastocytosis 94 7 108
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 11 343
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 6 730
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 537
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 4 235
G107 Deletion in 12 exon gene Jak-2 kinase 80 6 050
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 7 940
G152 Germinal mutation 60 4 537
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 7 940
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 680 51 421
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 83 6 276
G374 Prenatal DNA diagnosis (Wilson's Disease) 167 12 628
G381 PMP22(1.5-MB Del) 24 1 815
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 24 1 815
G383 PMP22 (1-BP INS, 325G; rs80338763) 24 1 815
G384 PMP22 (Ala67Thr: rs104894623) 24 1 815
G385 PMP22 (EX2-3DEL; nsv1197510) 24 1 815
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 6 428
G387 Genotyping on the RH factor, including heterozygous carrier 126 9 528
G390 Panel "Phacomatosis and hereditary cancer" 630 47 640
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 9 604
G408 Analysis of carriers of spinal ametropia 144 10 889
G409 Screening for hereditary diseases (2500 genes) 632 47 792
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 537
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 15 805
G412 Search 9 most frequent mutations in the CYP210HB gene 144 10 889
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 12 931
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 5 898
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 83 787
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 92 105
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 115 547
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 123 941
G420 Confirmation of previously found mutation sequencing by Sanger 107 8 091
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 107 8 091
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 637 48 170
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 85 6 428
G432 Neurodegenerative diseases - APOE gene genotyping 54 4 083
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 107 8 091
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 255 19 283
G435 BAS - screening of the coding region of the SOD1 gene 255 19 283
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 16 107
H250 Histology of tumor surgical samples 389 29 416
H299 Intraoperative (urgent) histology and cytology 200 15 124
H270 Histology of breast wide local excision (lumpectomy) specimen 389 29 416
H271 Histology of mastectomy speciment 367 27 752
H272 Histology of sentinel lymph node with IHC if necessary 227 17 166
H273 Histology of lymph node dissection speciment 213 16 107
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 9 604
M202 Hystology with supplementary staining for helicobacter pylori 227 17 166
M203 Multiple histology 3 samples and more 344 26 013
H204 Histology of the prostate punctates 358 27 072
H205 Histology of scrapings of the uterus 213 16 107
H206 Histology of the mammary gland punctates 213 16 107
H207 Histology of liver bioptates 213 16 107
H208 Histology of CT-guideline needle biopsy 397 30 021
H209 Histology of skin (PUNCH-biopsy) 213 16 107
H210 Histology of skin tumors 198 14 973
H211 Histology of bone marrow patho bioptate 213 16 107
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 11 797
H231 Consultation with the making of histology specimens with paraffin blocks 224 16 939
H232 Consultation with the making of specimens and immunohistochemistry 358 27 072
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 29 416
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 957
CYTOLOGY
M300 Citology / 1 lame 75 5 671
M301 Cytologic cervical smear (Pap Smear) 94 7 108
M302 Integrated cytology PAP-test and HPV typing 115 8 696
M303 Complex immunocytochemical study of thyroid neoplasms 450 34 029
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 898
Z303 Cytology of the mammary gland 75 5 671
Z304 Cytology of the thyroid gland punctate 117 8 848
Z305 Cytology of liquid 78 5 898
Z306 Cytology of endoscopic material 56 4 235
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 898
Z308 Cytology of surgical samples 78 5 898
Z309 Cytology of the lymph nodes punctate 94 7 108
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 898
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 20 1 512
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 21 022
I002 Immunohistochemical differential diagnosis of tumors 389 29 416
I003 Immunohistochemistry of one marker panel differential diagnosis 89 6 730
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 34 558
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 198 14 973
I006 Immunocytochemistry 256 19 359
I007 Immunohistochemistry with assessment of the mutational status of the ALK gene 220 16 636
I008 Complex histological and immunohistochemical analysis of biopsies of the bladder 256 19 359
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 11 797
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 30 248
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 255 19 283
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 308 23 291
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 313 23 669
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 313 23 669
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 313 23 669
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 301 22 762
I511 Determination of the mutational status of the NMYC gene by in situ hybridization in a tumor tissue sample 315 23 820
I512 Determination of the mutational status of the CMYC gene by in situ hybridization in a tumor tissue sample 315 23 820
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 21 703
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 21 703
G202 EGFR gene amplification (sensitivity to cetuximab) 259 19 586
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 13 460
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 17 846
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 8 469
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 24 803
G207 Determination of the methylation status of the promoter body and MGMT gene 177 13 385
G275 BCAM gene activity in cancer of the thyroid gland (biopsy study) 159 12 024
G276 IL4 gene activity in cancer of the thyroid gland (biopsy study) 159 12 024
G277 IL10 gene activity in cancer of the thyroid gland (biopsy study) 159 12 024
G278 TG gene activity in cancer of the thyroid gland (biopsy study) 159 12 024
G279 Active genes BCAM, IL4, IL10, TG thyroid cancer (study biopsy) 229 17 317
G283 Activity GATA2 gene for prostate cancer (study biopsy) 159 12 024
G284 Activity IGF1 gene for prostate cancer (study biopsy) 159 12 024
G285 Activity IGF2 gene for prostate cancer (study biopsy) 159 12 024
G286 Activity IL4 gene for prostate cancer (study biopsy) 159 12 024
G287 Activity IL10 gene for prostate cancer (study biopsy) 159 12 024
G288 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (study biopsy) 252 19 056
G368 Tissue test in ovarian cancer treatment 3213 242 966
G369 Agression degree in prostate cancer 3570 269 962
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 3543 267 921
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 184 210
G404 Express research of additional biomarkers 226 17 090
G405 Biological profiling of tumor (Caris Target Now) only NGS 3500 264 669
G406 Biological profiling of tumor (Caris Target Now) full profile 5700 431 032
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 83 787
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 162 12 250
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 162 12 250
G436 Molecular genetic study of mutations in the PIK3CA gene in a tumor tissue sample 145 10 965
G437 Molecular genetic research in the NRAS gene in biopsy/surgical tissue sample 131 9 906
G438 Иммуногистохимическое исследование экспрессии гена PD-L1 150 11 343
G439 Solo genetics standard: tumour tissue analysis (17 biomarkers) by the NGS method 737 55 732
G440 Solo Genetics Advanced: tumour tissue analysis (50 biomarkers) by NGS method 1357 102 616
G441 Comprehensive genetic study of thyroid tumors by NGS 1357 102 616
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 249 18 829
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 18 829
I504 Translocation in synovial sarcoma SYT/SSX 249 18 829
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 249 18 829

    Mobile application EMC